Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Gynecol Oncol. 2011 Nov 23;124(3):379–382. doi: 10.1016/j.ygyno.2011.11.032

Table 2.

FACT-G subscale scores between IV and IP arms

IV Arm IP Arm IV-IP
Assessment time point Mean SD Mean SD Mean Difference 95% CI p
Pre-Randomization N=187 N=168
 PWB 19.8 5.7 18.3 6.1 1.5 0.3~2.7 0.016
 SWB 23.5 4.0 23.0 4.1 0.5 −0.3~1.4 0.227
 EWB 16.7 4.7 16.6 4.9 0.1 −0.9~1.1 0.907
 FWB 16.1 6.4 14.8 5.9 1.3 −0.0~2.5 0.051
Pre-Cycle 4 N=169 N=143
 PWB 18.9 5.4 16.3 5.9 2.6 1.4~3.8 <0.001
 SWB 23.1 3.5 22.0 3.8 1.0 0.3~1.8 0.009
 EWB 18.4 3.9 17.3 4.5 1.1 0.3~1.9 0.006
 FWB 16.5 6.5 14.3 5.5 2.2 1.1~3.4 <0.001
3~6 weeks after treatment N=168 N=154
 PWB 20.4 5.2 18.8 5.7 1.7 0.6~2.9 0.003
 SWB 22.7 3.7 22.4 4.5 0.3 −0.5~1.1 0.450
 EWB 18.1 4.2 17.8 4.4 0.3 −0.5~1.1 0.407
 FWB 18.4 6.2 16.0 6.1 2.5 1.2~3.7 <0.001
12 months after treatment N=137 N=135
 PWB 22.7 4.8 22.8 5.1 -0.1 −1.2~1.0 0.852
 SWB 22.9 3.8 22.8 4.7 0.2 −0.7~1.1 0.693
 EWB 18.5 4.3 18.3 4.2 0.3 −0.6~1.2 0.523
 FWB 21.4 6.0 21.5 5.9 −0.1 −1.4~1.1 0.822

Functional Assessment of Cancer Therapy-General (FACT-G), PWB=physical well-being, SWB=social well-being, EWB=emotional well-being, FWB=functional well-being, SD=standard deviation, CI=confidence interval

The mean scores (mean ± S.E) in the follow-up assessments are the least squared means estimated from the fitted linear mixed model and adjusted for baseline scores and age.